Premium Nahrungsergänzungsmittel | artgerecht

Tauroursodeoxycholic Acid (TUDCA) – Effects & Uses

Tauroursodeoxycholic acid (TUDCA) is a naturally occurring bile acid with potent cytoprotective properties. It is used medically and as a dietary supplement.

Regular tips about health Regular tips about health

Things worth knowing about "Tauroursodeoxycholic Acid"

Tauroursodeoxycholic acid (TUDCA) is a naturally occurring bile acid with potent cytoprotective properties. It is used medically and as a dietary supplement.

What is Tauroursodeoxycholic Acid?

Tauroursodeoxycholic acid (abbreviated as TUDCA) is a water-soluble bile acid that occurs naturally in small amounts in the human body. It is formed when ursodeoxycholic acid (UDCA) is conjugated with the amino acid taurine by intestinal bacteria. TUDCA belongs to the group of secondary bile acids and is well known for its strong cytoprotective (cell-protecting) and anti-inflammatory properties.

Mechanism of Action

TUDCA exerts its effects through several molecular mechanisms:

Inhibition of endoplasmic reticulum (ER) stress: TUDCA stabilizes the endoplasmic reticulum, a key cell organelle, thereby preventing the accumulation of misfolded proteins that can lead to cell death.
Anti-apoptotic effects: TUDCA inhibits programmed cell death (apoptosis) by blocking mitochondrial signaling pathways that trigger cellular destruction.
Antioxidant activity: The compound reduces oxidative stress caused by free radicals, which can damage cells and tissues.
Anti-inflammatory effects: TUDCA modulates inflammatory signaling pathways, helping to attenuate chronic inflammatory processes.
Bile acid regulation: As a hydrophilic bile acid, TUDCA displaces toxic, hydrophobic bile acids from the bile acid pool, thereby protecting liver and intestinal cells.

Medical Applications

Liver Diseases

TUDCA has traditionally been used to treat gallstones and cholestatic liver diseases (conditions characterized by impaired bile flow). In clinical practice, it is being studied as an adjunct to UDCA in primary biliary cholangitis (PBC) as well as in alcoholic and non-alcoholic fatty liver disease (NAFLD/NASH). Studies suggest that TUDCA can improve liver enzyme levels and protect overall liver function.

Neurological Conditions

In basic research and early clinical trials, TUDCA is being investigated for its neuroprotective effects. Potential applications include:

Amyotrophic lateral sclerosis (ALS): A clinical trial indicated that TUDCA may slow disease progression.
Alzheimer's and Parkinson's disease: Preclinical data suggest a protective effect on nerve cells.
Huntington's disease: Animal studies show promising neuroprotective effects.

Metabolic Disorders and Diabetes

TUDCA may improve insulin sensitivity and reduce ER stress in pancreatic beta cells, which could be relevant for the treatment of type 2 diabetes. Human studies have demonstrated initial positive effects on insulin resistance.

Eye Diseases

In preclinical models, TUDCA has shown protective effects on retinal cells (photoreceptors and retinal ganglion cells), making it a potential candidate for treating conditions such as retinitis pigmentosa or glaucoma.

TUDCA as a Dietary Supplement

TUDCA is freely available as a dietary supplement in many countries. It is commonly used by athletes and biohackers for liver support, particularly alongside substances that may place a burden on the liver. Typical dosages in dietary supplements range from 250 mg to 1000 mg per day. Clinical studies have sometimes used higher doses. Medical consultation before use is recommended.

Safety and Side Effects

TUDCA is generally considered well-tolerated. The following side effects have been reported in clinical studies:

Diarrhea or loose stools (at higher doses)
Abdominal pain or bloating
Nausea (rare)

Individuals with existing bile duct disorders, pregnant or breastfeeding women should only take TUDCA after consulting a physician. Interactions with medications metabolized by the liver are possible.

References

Vang S. et al. - The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases. Global Advances in Health and Medicine, 2014.
Ozcan U. et al. - Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes. Science, 2006.
Elia A.E. et al. - Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. European Journal of Neurology, 2016.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.